Eupraxia Pharmaceuticals Balance Sheet (2022-2026)

Reported Financials

Eupraxia Pharmaceuticals Quarterly Balance Sheet

Periods 12 quarters

Latest Jun 2026

Eupraxia Pharmaceuticals reported total assets of $0.14B and total liabilities of $0.01B for the quarter ended Jun 2026, up 492.9% year over year. This balance sheet covers 12 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Dec2022	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Receivables - AccuredAcc. Int. Receivables	-0.00B											-0.00B
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.02B	0.02B	0.04B	0.02B	0.01B	0.03B	0.03B	0.02B	0.09B	0.08B	0.06B	0.05B
Receivables - NetNet Receivables		0.00B				0.00B				0.00B
Receivables - OtherOther Receivables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Receivables		0.00B				0.00B				0.00B
Prepaid Assets	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Current Assets	0.02B	0.02B	0.04B	0.02B	0.01B	0.03B	0.03B	0.02B	0.09B	0.09B	0.14B	0.14B
Non-Current Assets
Property, Plant & Equipment (Net)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non-Current Assets	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Non-Current Assets	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Assets	0.02B	0.02B	0.04B	0.02B	0.01B	0.03B	0.03B	0.02B	0.09B	0.09B	0.15B	0.14B
Liabilities
Current Liabilities
Accounts Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B
Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B
Short term Debt	0.00B
Current Leases	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Total Current Liabilities	0.00B	0.02B		0.01B	0.00B	0.00B			0.00B	0.01B	0.01B	0.01B
Non-Current Liabilities
Non-Current Debt	0.00B	0.00B	0.00B	0.00B
Convertible Debt	0.01B	0.01B	0.01B	0.00B		-0.00B
Minority Interest	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Operating Leases	0.00B	0.00B	0.00B	0.00B	0.00B				0.00B	0.00B	0.00B	0.00B
Total Liabilities	0.01B	0.02B	0.02B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B
Shareholder's Equity
Total Debt	0.00B	0.00B	0.00B	0.00B
Common Equity	0.01B	0.00B	0.02B	0.01B	0.01B	0.03B	0.03B	0.02B	0.09B	0.08B	0.14B	0.13B
Liabilities and Shareholders Equity	0.02B	0.02B	0.04B	0.02B	0.01B	0.03B	0.03B	0.02B	0.09B	0.09B	0.15B	0.14B
Retained Earnings	-0.08B	-0.11B	-0.11B	-0.12B	-0.12B	-0.13B	21,947,012.14B	-0.15B	-0.15B	-0.17B	-0.18B	-0.20B
Preferred Shares						0.03B				0.03B

Eupraxia Pharmaceuticals EPRX Balance Sheet (2022-2026)

Eupraxia Pharmaceuticals Quarterly Balance Sheet

Create an account

Sign In

Reset Password